Premium
Increased natural killer cells and decreased CD3 + CD8 + CD62L + T cells in CML patients who sustained complete molecular remission after discontinuation of imatinib
Author(s) -
Ohyashiki Kazuma,
Katagiri Seiichiro,
Tauchi Tetsuzo,
Ohyashiki Junko H,
Maeda Yasuhiro,
Matsumura Itaru,
Kyo Taiichi
Publication year - 2012
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.2011.08939.x
Subject(s) - imatinib , medicine , discontinuation , dasatinib , imatinib mesylate , minimal residual disease , cd8 , gastroenterology , oncology , immunology , myeloid leukemia , immune system , leukemia